Accessibility Menu
Pro Medicus logo

Pro Medicus(OTC) PMCUF

Market Cap$15.04BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+12,611%
5 Year+212%
1 Year-27%
1 Month+19%
$144.00
+2.89%
+4.04Today
Pro Medicus last closing stock price
MetricPriceDate
Last closeUSD 144.002026-08-21
Pro Medicus stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+10.82%USD 129.942026-08-13
1 month+19.01%USD 121.002026-07-22
3 month+57.17%USD 91.622026-05-22
Year to date-0.84%USD 145.232025-12-30
1 year-26.62%USD 196.242025-08-20
3 year+219.36%USD 45.092023-08-21
5 year+212.38%USD 46.102021-08-19
Since inception+12,610.71%USD 1.132008-05-28

Pro Medicus Financials at a Glance

Market Cap

$15.04BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$474.43M

Net Income (TTM)

A$380.36M

EPS (TTM)

$1.70

P/E Ratio

84.37

Dividend

$0.42

Beta (Volatility)

0.29 (Low)

Price

$144.00

Volume

48

Open

$144.14

Previous Close

$144.00

Daily Range

$144.00 - $144.14

52-Week Range

$74.52 - $210.25

Estimated Earnings Date

Feb 16, 2027

PMCUF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pro Medicus

Pro Medicus Limited is a prominent developer and provider of advanced healthcare imaging software and support services. Established in 1983 and based in Richmond, Australia, the company serves a diverse clientele, including hospitals and diagnostic imaging facilities across Australia, North America, and Europe.

Products and Services
  • Proprietary Radiology Information System (Visage RIS) for efficient practice management
  • Promedicus.net, an e-health platform for enhanced patient care
  • Advanced imaging software for 2D, 3D, and 4D medical images
Growth Outlook
  • Revenue increased to AUD 124.73 million in the latest quarter
  • Net income reached AUD 171.16 million, showcasing strong profitability
  • Operating income margin of 72.66% indicates operational efficiency
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 471.4 million
  • Net profit margin of 97.56% reflects exceptional profitability
  • Current ratio of 6.22 indicates strong liquidity position
Pro Medicus Limited has established itself as a leader in the healthcare information services sector, driven by its innovative software solutions. The company's recent financial performance highlights its robust growth trajectory, with significant increases in both revenue and net income. The impressive operating income margin underscores the efficiency of its operations, while a strong liquidity position ensures the company can navigate future challenges effectively. With a focus on advanced imaging technologies and a commitment to enhancing patient care, Pro Medicus is well-positioned for continued success in the evolving healthcare landscape.
AI Generated • Aug 15, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

153

CEO

Sam Aaron Hupert, MD

Website

www.promed.com.au

Headquarters

Richmond, VIC 3121, AU

PMCUF Financials

Key Financial Metrics (TTM)

Gross Margin

80.69%

Operating Margin

74.94%

Net Income Margin

101.40%

Return on Equity

63.19%

Return on Capital

43.28%

Return on Assets

43.49%

Earnings Yield

1.19%

Dividend Yield

0.29%

Payout Ratio

24.41%

Stock Overview

Market Cap

$15.04BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

104.47M

Volume

48

Avg. Volume

383.766

Financials (TTM)

Gross Profit

A$400.44M

Operating Income

A$354.92M

EBITDA

A$368.25M

Operating Cash Flow

A$251.73M

Capital Expenditure

-A$882.64K

Free Cash Flow

A$250.84M

Cash & ST Invst.

A$250.27M

Total Debt

A$2.23M

Pro Medicus Performance Analysis

Pro Medicus annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 84,020,79424.0%
20242024-06-30AUD 105,843,72226.0%
20252025-06-30AUD 137,932,44830.3%
20262026-06-30AUD 177,325,79228.6%
Pro Medicus sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3111.2%
Q42025-06-3019.1%
Q22025-12-317.7%
Q42026-06-309.6%
Pro Medicus annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD 0.3926.6%
20242024-06-30AUD 0.5232.9%
20252025-06-30AUD 0.7137.5%
20262026-06-30AUD 1.72141.0%
Pro Medicus sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-318.9%
Q42025-06-3024.5%
Q22025-12-31167.2%
Q42026-06-30-45.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$136.72M

+56.4%

Gross Profit

A$114.82M

+31.6%

Gross Margin

83.99%

N/A

Market Cap

$15.04BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$98.32M

N/A

Employees

153

N/A

Net Income

A$93.99M

+101.9%

EBITDA

A$109.71M

+71.5%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$250.27M

+61.0%

Total Debt

A$2.23M

+7.7%

Accounts Receivable

A$100.21M

+108.5%

Inventory

A$0.00

-100.0%

Long Term Debt

A$1.46M

-3.7%

Short Term Debt

A$767.92K

+38.9%

Return on Assets

43.49%

N/A

Return on Invested Capital

35.15%

N/A

Free Cash Flow

A$66.86M

+26.6%

Operating Cash Flow

A$67.04M

+26.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GIKLYGrifols, S.A.
$5.78+13.33%
SNNUFSmith & Nephew plc
$15.75+1.74%
SONVYSonova Holding AG
$59.79-2.05%
FMCQFFresenius Medical Care AG
$43.01-16.39%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.80-0.03%
BITOProShares Trust - ProShares Bitcoin ETF
$10.59-0.01%
NVDANvidia
$210.58-0.01%
CRECre8 Enterprise
$6.23+1.42%

Questions About PMCUF

What is the current price of Pro Medicus?

Pro Medicus is trading at $144.00 per share.

What is the 52-week range for Pro Medicus?

Over the past 52 weeks, Pro Medicus has traded between $74.52 and $210.25.

How much debt does Pro Medicus have?

As of the most recent reporting period, Pro Medicus reported total debt of A$1.55M.

How much cash does Pro Medicus have on hand?

Pro Medicus reported A$101.48M in cash and cash equivalents in its most recent financial results.

What is Pro Medicus’s dividend yield?

Pro Medicus currently has a dividend yield of 0.29%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services